A.P. Pharma to Present at Merriman Curhan Ford ''Investor Summit 2006'' on September 18
09/12/2006
|
REDWOOD CITY, Calif., Sep 12, 2006 (BUSINESS WIRE) -- A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical company, today announced it will present at the Merriman Curhan Ford "Investor Summit 2006" to be held September 18-20 at the Mark Hopkins Hotel in San Francisco.
Dr. Paul Goddard, A.P. Pharma's chairman, is scheduled to speak on Monday, September 18, at 4:00 p.m. Pacific time (7:00 p.m. Eastern time) and will discuss the Company's strategic initiatives and provide a business update.
Interested parties can access a live audio webcast at www.appharma.com. An archived presentation will be available on the Web site for 30 days.
About A.P. Pharma
A.P. Pharma is a specialty pharmaceutical company focused on the development of ethical (prescription) pharmaceuticals utilizing its proprietary polymer-based drug delivery systems. The Company's primary focus is the development and commercialization of its bioerodible injectable and implantable systems under the trade name Biochronomer. Initial target areas of application for the Company's drug delivery technology include anti-nausea, pain management, anti-inflammation and DNA/RNAI applications. For further information visit the Company's web site at www.appharma.com.
SOURCE: A.P. Pharma, Inc.
Investor Relations Contacts:
Lippert/Heilshorn & Associates
Zachary Bryant (zbryant@lhai.com)
Don Markley (dmarkley@lhai.com)
Bruce Voss (bvoss@lhai.com)
310-691-7100